おすすめコンテンツ

BCGが読む経営の論点2023

不確実な時代だからこそ、世の中の変化と流れを読み解き、他社に先駆けて有効な手を打つことが競争優位性の構築につながります。本書では、序章で不確実性に対応するためのシナリオプランニングの手法を紹介し、第1章以降でBCGが重要と考える10の潮流について変化の本質と経営へのインパクトを考察し2023年にとるべきアクションを提示します。

実践 BCG流 病院経営――バリューベース・ヘルスケア時代の病院経営

さまざまな医療機関への経営改善支援の経験を基に、医療の質と生産性をともに高めるための考え方と実践的手法について解説します。経営層と現場が一体となった経営改善活動の推進に向け明日から取り組める打ち手が盛り込まれています。

BCG流　病院経営戦略: DPC時代の医療機関経営

日本赤十字社の協力の下、医療現場の経営改善に向けて行った実証的研究を基に、医療の質と生産性を向上させる病院経営戦略の考え方と実践的手法について解説します。

Biopharma

Biopharma’s Role in Achieving Health Equity

Companies can take four steps to address the inequitable health outcomes that marginalized and underserved communities experience in the US.

Biopharma Is Betting Big on Digital and Data. Are Companies Organized for Success?

For their investments to pay off, biopharma companies need the right organizational setup and ways of working.

For Biopharma, a Rising Tide—and Choppy Waters

Powerful trends are shaping a promising yet challenging decade for the industry.

Get the Right Therapies to the Right Patients with Next-Gen Analytics

To advance from promise to value, biopharma companies need to articulate and execute a bold vision for analytics as a fully scaled, continuously applied internal capability.

Health Care Payers, Providers, Systems, and Services

Price Transparency in US Health Care Demands Swift Action

A new regulation makes detailed pricing data widely available for the first time. Providers and insurers need to prepare now for a changed competitive playing field.

Health Care’s New Promise to Employees

An employee value proposition can help companies keep current employees and attract new ones.

In a Crowded Medicare Advantage Market, Know Thy Customer

As competition grows, plans need to win their members’ trust—and their renewal—every year. Here’s how to do it.

Designing the Digital Health Care Systems That People Deserve

The transformation agenda for health care is government led, tailored to your country’s capabilities, and focused on better outcomes. Use this domains-and-roles framework to set your health care systems on track.

Medical Devices and Technology

Why Ottobock Leads with “Social” in ESG: An Interview with CEO Philipp Schulte-Noelle

A global leader in prostheses, Ottobock set out to also become the ESG leader in its field. The key: measuring the socioeconomic benefit of its products.

Monitoring Patient Health from Hospital to Home

When patients move through hospital units—and eventually are discharged—their vital information doesn’t follow. But smarter solutions can track patient data across settings.

For Cutting-Edge Innovations, the US Pulls Ahead of the EU in Medtech Regulation

A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.

The Rise of the Next Generation of Medtech “Milkmen”

A next-generation commercial model is needed fast. Those who adopt it quickly will be rewarded handsomely.

Global Health

BCG Executive Perspectives: How to End the Global Pandemic in 2022

BCG Executive Perspectives offer insights on global topics that matter most to leaders in the public and private sectors. Our latest edition explores the evolving landscape of business and leisure travel, examining how companies within and beyond the industry can adapt to new trends.

Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?

Play Video

What It Takes to Crush a Pandemic

BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—while sharing a creative approach to vaccine research and development.

• Anticipating the Spread of COVID-19 with Scenario Planning

  BCG’s scenario-planning tool, PLAN, helps you explore the potential impact of COVID-19 in the United States at a region, state, and county level.
• BD’s Vincent Forlenza on Transforming in a Rapidly Changing Industry

  Vincent Forlenza, CEO of BD, has navigated multibillion-dollar acquisitions while driving a full-scale organizational transformation. BD’s success, amid enormous change, hinges on its purpose-driven culture.
• Karalee Close on The Digital Opportunity in Healthcare

  Using digital to harness the next generation of science and the exponential growth of health care data.
• Accelerating Drug Development Today

  Sit in on a conversation with BCG pharma leaders as they discuss advancing drug development with new tools, real-world data, digitization, and collaboration across cross-functional teams.
• Using Big Data to Measure Health Care Outcomes

  According to BCG's Sanjay Saxena, the opportunity for using big data and analytics in measuring outcomes is huge. But the trick for payers and providers will be understanding the data—and knowing which questions to ask about it.
• Jon Kaplan on Health Care Payers

  BCG’s Jon Kaplan explains how health care payers can provide the strongest portfolio of product offerings and best service in today’s marketplace.